Polycystic ovary syndrome and abnormal glucose tolerance

Helena J Teede and Bronwyn G A Stuckey
Med J Aust 2007; 187 (6): . || doi: 10.5694/j.1326-5377.2007.tb01271.x
Published online: 17 September 2007

Potentially serious metabolic sequelae make diagnosis and intervention imperatives

Polycystic ovary syndrome (PCOS) is the most common endocrine abnormality of women of reproductive age. The diagnosis is based on the presence of two of three criteria — ovulatory disturbance, hyperandrogenism, and polycystic ovaries on ultrasound. However, in most women, insulin resistance is central to the pathogenesis of the syndrome, with hyperinsulinaemia driving both androgen production and androgen bioavailability as the key diagnostic feature.1-3 In PCOS, insulin resistance not only contributes to symptoms, but also has serious sequelae including infertility, impaired glucose tolerance, a fourfold to sevenfold increase in diabetes and a potentially increased risk of cardiovascular disease.3

  • Helena J Teede1,2
  • Bronwyn G A Stuckey3,4,5

  • 1 Southern Health, Melbourne, VIC.
  • 2 The Jean Hailes Foundation for Women’s Health, Monash Institute of Health Services Research, Monash University, Melbourne, VIC.
  • 3 Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Perth, WA.
  • 4 Keogh Institute for Medical Research, Perth, WA.
  • 5 School of Medicine and Pharmacology, University of Western Australia, Perth, WA.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.